NZ506049A - Steroid derivatives; useful for selectively supplementing oestrogen deficiency in the central nervous system - Google Patents
Steroid derivatives; useful for selectively supplementing oestrogen deficiency in the central nervous systemInfo
- Publication number
- NZ506049A NZ506049A NZ506049A NZ50604999A NZ506049A NZ 506049 A NZ506049 A NZ 506049A NZ 506049 A NZ506049 A NZ 506049A NZ 50604999 A NZ50604999 A NZ 50604999A NZ 506049 A NZ506049 A NZ 506049A
- Authority
- NZ
- New Zealand
- Prior art keywords
- useful
- nervous system
- central nervous
- alkyl
- independently
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/30—Oestrogens
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Diabetes (AREA)
- Psychiatry (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Reproductive Health (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
The steroids of the formula shown are useful for selectively supplementing estrogen deficiency in the central nervous system without affecting other organs or systems. The variables are defined as follows: R1 is H, -OH, or alkoxy; R2 is H, alkyl, acyl, or -SO2NR10R11 (where R10 and R11 are independently H or alkyl, or together with the nitrogen atom to which they are attached form a pyrrolidino, piperidino or morpholino ring); R3 is H or -OH; R4 is H, -OH, or alkyl; R5 and R6 are independently H or halogen; R7 is H or methyl; R8 is H, -OH, =O, or a group of formula -CR12R13 (in which R12 and R13 are independently H or halogen); R9 is methyl or ethyl; Z is a C,C double bond or an optionally substituted cyclopropane ring; The >CR5R6 is either in the a or b position, R7 being in the b position if >CR5R6 is in the a position, and vice versa.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DE19807264 | 1998-02-20 | ||
| DE1998121831 DE19821831A1 (en) | 1998-05-15 | 1998-05-15 | Selectively supplementing estrogen deficiency in the central nervous system, using 14,15-cyclopropano estrane steroid compounds |
| PCT/DE1999/000353 WO1999042108A1 (en) | 1998-02-20 | 1999-02-10 | Pharmaceutical preparations for selectively supplementing oestrogen deficiency in the central nervous system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ506049A true NZ506049A (en) | 2002-09-27 |
Family
ID=26044035
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ506049A NZ506049A (en) | 1998-02-20 | 1999-02-10 | Steroid derivatives; useful for selectively supplementing oestrogen deficiency in the central nervous system |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP1056460B1 (en) |
| JP (1) | JP2002503694A (en) |
| KR (1) | KR20010041107A (en) |
| CN (1) | CN1291102A (en) |
| AT (1) | ATE252388T1 (en) |
| AU (1) | AU739071C (en) |
| BG (1) | BG104689A (en) |
| BR (1) | BR9909205A (en) |
| CA (1) | CA2321498A1 (en) |
| CZ (1) | CZ291764B6 (en) |
| DE (1) | DE59907446D1 (en) |
| EA (1) | EA002707B1 (en) |
| EE (1) | EE03906B1 (en) |
| HU (1) | HUP0100742A3 (en) |
| ID (1) | ID27069A (en) |
| IL (1) | IL137727A0 (en) |
| IS (1) | IS5571A (en) |
| NO (1) | NO20004153L (en) |
| NZ (1) | NZ506049A (en) |
| PL (1) | PL342313A1 (en) |
| SK (1) | SK12152000A3 (en) |
| TR (1) | TR200002400T2 (en) |
| UA (1) | UA57830C2 (en) |
| WO (1) | WO1999042108A1 (en) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2253318T3 (en) | 2001-11-07 | 2006-06-01 | Schering Ag | IN VITRO LIGAND CROSSING OF THE STROGEN RECEIVER. |
| CN112189624A (en) * | 2020-09-08 | 2021-01-08 | 山东第一医科大学(山东省医学科学院) | Method for constructing and identifying female AD model by using receptor gene silencing technology |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4897389A (en) * | 1984-10-29 | 1990-01-30 | Chaovanee Aroonsakul | Treating central nervous system diseases |
| US4791099A (en) * | 1984-10-29 | 1988-12-13 | Chaovanee Aroonsakul | Method of treatment for central nervous system diseases such as Alzheimer's's disease |
| DE4239946C2 (en) * | 1992-11-27 | 2001-09-13 | Jenapharm Gmbh | Estrane derivatives with a 14alpha, 15alpha-methylene group and process for their preparation |
| US5554601A (en) * | 1993-11-05 | 1996-09-10 | University Of Florida | Methods for neuroprotection |
| DE4338314C1 (en) * | 1993-11-10 | 1995-03-30 | Jenapharm Gmbh | Pharmaceutical preparations for the prophylaxis and therapy of radical-mediated cell damage |
| DE4429397C2 (en) * | 1994-08-09 | 2003-11-20 | Jenapharm Gmbh | Estra-1,3,5 (10) -triene derivatives, processes for their preparation and pharmaceutical compositions containing these compounds |
| DE19524937A1 (en) * | 1995-07-08 | 1997-01-09 | Jenapharm Gmbh | Pharmaceutical preparations for the prophylaxis and therapy of radical-mediated cell damage and for drug substitution in men |
| WO1997003661A1 (en) * | 1995-07-24 | 1997-02-06 | University Of Florida Research Foundation, Incorporated | Use of non-estrogen polycyclic phenol compounds for the manufacture of a medicament for conferring neuroprotection to cells |
-
1999
- 1999-02-10 NZ NZ506049A patent/NZ506049A/en unknown
- 1999-02-10 BR BR9909205-0A patent/BR9909205A/en not_active IP Right Cessation
- 1999-02-10 CZ CZ20002938A patent/CZ291764B6/en not_active IP Right Cessation
- 1999-02-10 EA EA200000858A patent/EA002707B1/en not_active IP Right Cessation
- 1999-02-10 EE EEP200000477A patent/EE03906B1/en not_active IP Right Cessation
- 1999-02-10 CA CA002321498A patent/CA2321498A1/en not_active Abandoned
- 1999-02-10 SK SK1215-2000A patent/SK12152000A3/en unknown
- 1999-02-10 AU AU29209/99A patent/AU739071C/en not_active Ceased
- 1999-02-10 HU HU0100742A patent/HUP0100742A3/en unknown
- 1999-02-10 ID IDW20001592A patent/ID27069A/en unknown
- 1999-02-10 WO PCT/DE1999/000353 patent/WO1999042108A1/en not_active Application Discontinuation
- 1999-02-10 AT AT99910118T patent/ATE252388T1/en not_active IP Right Cessation
- 1999-02-10 DE DE59907446T patent/DE59907446D1/en not_active Expired - Fee Related
- 1999-02-10 EP EP99910118A patent/EP1056460B1/en not_active Expired - Lifetime
- 1999-02-10 JP JP2000532123A patent/JP2002503694A/en not_active Abandoned
- 1999-02-10 TR TR2000/02400T patent/TR200002400T2/en unknown
- 1999-02-10 PL PL99342313A patent/PL342313A1/en unknown
- 1999-02-10 CN CN99803170A patent/CN1291102A/en active Pending
- 1999-02-10 KR KR1020007009148A patent/KR20010041107A/en not_active Application Discontinuation
- 1999-02-10 IL IL13772799A patent/IL137727A0/en unknown
- 1999-10-02 UA UA2000095399A patent/UA57830C2/en unknown
-
2000
- 2000-07-24 IS IS5571A patent/IS5571A/en unknown
- 2000-08-15 BG BG104689A patent/BG104689A/en unknown
- 2000-08-18 NO NO20004153A patent/NO20004153L/en not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BG104689A (en) | 2001-04-30 |
| AU2920999A (en) | 1999-09-06 |
| BR9909205A (en) | 2000-11-14 |
| WO1999042108A1 (en) | 1999-08-26 |
| EP1056460B1 (en) | 2003-10-22 |
| PL342313A1 (en) | 2001-06-04 |
| DE59907446D1 (en) | 2003-11-27 |
| TR200002400T2 (en) | 2000-11-21 |
| JP2002503694A (en) | 2002-02-05 |
| NO20004153L (en) | 2000-10-09 |
| SK12152000A3 (en) | 2001-02-12 |
| EE03906B1 (en) | 2002-12-16 |
| EP1056460A1 (en) | 2000-12-06 |
| HUP0100742A2 (en) | 2001-09-28 |
| IL137727A0 (en) | 2001-10-31 |
| ID27069A (en) | 2001-02-22 |
| UA57830C2 (en) | 2003-07-15 |
| EA002707B1 (en) | 2002-08-29 |
| CZ291764B6 (en) | 2003-05-14 |
| CA2321498A1 (en) | 1999-08-26 |
| CN1291102A (en) | 2001-04-11 |
| ATE252388T1 (en) | 2003-11-15 |
| AU739071C (en) | 2002-04-11 |
| HUP0100742A3 (en) | 2002-07-29 |
| AU739071B2 (en) | 2001-10-04 |
| CZ20002938A3 (en) | 2001-01-17 |
| EE200000477A (en) | 2001-12-17 |
| KR20010041107A (en) | 2001-05-15 |
| EA200000858A1 (en) | 2001-04-23 |
| NO20004153D0 (en) | 2000-08-18 |
| IS5571A (en) | 2000-07-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR100263496B1 (en) | Taxol derivatives and preparation method thereof | |
| NO20002676L (en) | Androgenic steroid compounds and a process for the preparation and use of the same | |
| AU576199B2 (en) | Beta-carboline derivatives | |
| NZ506049A (en) | Steroid derivatives; useful for selectively supplementing oestrogen deficiency in the central nervous system | |
| DK0988312T3 (en) | 17beta-allyloxy (thio) alkyl androstane derivatives for modulating meiosis | |
| DK1163258T3 (en) | Derivatives of 22R-hydroxycholesta-8,14-diene for the inhibition of meiosis | |
| ES484683A1 (en) | Tetrahydrothiopyrano[2,3-b]indole derivatives | |
| GB2020280A (en) | 4,5-Dihydroimidazol-Z-yl Amino Substituted Isoquinolines | |
| UA41890C2 (en) | process for the preparation of derivatives of 2-perfluoroalkyl-3-oxazoline-5-on (variants), perfluoroalkanoylaminonitrile intermediary compounds | |
| FI964278A0 (en) | Process for the preparation of 5,6-dihydroxy-2-amino-1,2,3,4-tetrahydronaphthalene derivatives | |
| YU402A (en) | New 2,3-benzodiazepine derivatives | |
| TR199901956T2 (en) | A process for the preparation of 4H-4-Oxo-quinolysis-3-carboxylic acid derivatives. | |
| TW358087B (en) | Method for preparing carbamoylmethylurea derivatives | |
| DK1137660T3 (en) | 22S-hydroxycholesta-8,14-diene derivatives with meios regulating activity | |
| TW326043B (en) | Method for preparing coumarin and derivatives thereof | |
| YU151591A (en) | PROCESS FOR ETHYNYLATION OF 17-KETOSTEROIDS | |
| NZ510556A (en) | General epoxidation reaction for compounds with olefinic double bonds especially for synthesis for epoxymexrenone |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PSEA | Patent sealed | ||
| RENW | Renewal (renewal fees accepted) |